Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125732671 | 12573267 | 1 | I | 20160319 | 20160705 | 20160720 | 20160720 | EXP | FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-055849 | BRISTOL MYERS SQUIBB | 87.09 | YR | M | Y | 0.00000 | 20160720 | CN | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125732671 | 12573267 | 1 | PS | COUMADINE | WARFARIN SODIUM | 1 | Oral | UNK UNK, QD | U | 9218 | TABLET | QD | |||||||
| 125732671 | 12573267 | 2 | SS | CALCIPARINE | HEPARIN CALCIUM | 1 | Subcutaneous | UNK | U | 0 | |||||||||
| 125732671 | 12573267 | 3 | SS | HUMALOG | INSULIN LISPRO | 1 | Unknown | U | 0 | ||||||||||
| 125732671 | 12573267 | 4 | SS | LANTUS | INSULIN GLARGINE | 1 | Unknown | U | 0 | ||||||||||
| 125732671 | 12573267 | 5 | C | TAHOR | ATORVASTATIN CALCIUM | 1 | Unknown | U | 0 | ||||||||||
| 125732671 | 12573267 | 6 | C | KARDEGIC | ASPIRIN LYSINE | 1 | Unknown | U | 0 | ||||||||||
| 125732671 | 12573267 | 7 | C | CORDARONE | AMIODARONE HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
| 125732671 | 12573267 | 8 | C | LASILIX /00032601/ | FUROSEMIDE | 1 | Unknown | U | 0 | ||||||||||
| 125732671 | 12573267 | 9 | C | MIRCERA | METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA | 1 | Unknown | U | 0 | ||||||||||
| 125732671 | 12573267 | 10 | C | LEVOTHYROX | LEVOTHYROXINE | 1 | Unknown | U | 0 | ||||||||||
| 125732671 | 12573267 | 11 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Unknown | U | 0 | ||||||||||
| 125732671 | 12573267 | 12 | C | PYOSTACINE | PRISTINAMYCIN | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125732671 | 12573267 | 1 | Atrial fibrillation |
| 125732671 | 12573267 | 2 | Atrial fibrillation |
| 125732671 | 12573267 | 3 | Diabetes mellitus |
| 125732671 | 12573267 | 4 | Diabetes mellitus |
| 125732671 | 12573267 | 5 | Product used for unknown indication |
| 125732671 | 12573267 | 6 | Product used for unknown indication |
| 125732671 | 12573267 | 7 | Product used for unknown indication |
| 125732671 | 12573267 | 8 | Product used for unknown indication |
| 125732671 | 12573267 | 9 | Product used for unknown indication |
| 125732671 | 12573267 | 10 | Product used for unknown indication |
| 125732671 | 12573267 | 11 | Product used for unknown indication |
| 125732671 | 12573267 | 12 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125732671 | 12573267 | HO |
| 125732671 | 12573267 | OT |
| 125732671 | 12573267 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125732671 | 12573267 | Anaemia | |
| 125732671 | 12573267 | Bundle branch block | |
| 125732671 | 12573267 | Craniocerebral injury | |
| 125732671 | 12573267 | Death | |
| 125732671 | 12573267 | Dialysis | |
| 125732671 | 12573267 | Fall | |
| 125732671 | 12573267 | Hypoglycaemic seizure | |
| 125732671 | 12573267 | Rectal haemorrhage | |
| 125732671 | 12573267 | Staphylococcal sepsis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125732671 | 12573267 | 1 | 2014 | 0 | ||
| 125732671 | 12573267 | 2 | 2015 | 0 |